RTW INVESTMENTS LP
Adviser information for RTW INVESTMENTS LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 59 |
---|---|
Investment Advisory/Research | 32 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 10 | $8.8B |
Non-Discretionary | 0 | $0 |
Total | 10 | $8.8B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 10 | $8.8B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 70 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
40 10TH AVENUE7TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 8:00AM - 6:00PM
Tel: 646-597-6980, Fax: 646-597-6998
Chief Compliance Officer
DARSHAN VISHNU PATEL
40 10TH AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel:
646-876-0039
Fax:
646-597-6998
D*@***********M
(Full email address available in API data)
Regulatory Contact
ABDI MOAZAMI
DIRECTOR OF COMPLIANCE
40 10TH AVENUE
7TH FLOOR
NEW YORK
NY
United States
Tel:
646-343-9296
Fax:
646-597-6998
A*@***********M
(Full email address available in API data)
Industry Affiliates
4010 ROYALTY FUND GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
HSAC 2 HOLDINGS, LLC | Sponsor, GP, manager of pooled investment vehicles |
RTW FUND GROUP GP, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
RTW GLOBAL INVESTMENTS LTD. | Other investment adviser, including financial planners |
RTW HOLDING LIMITED | Sponsor, GP, manager of pooled investment vehicles |
RTW HOLDINGS, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
4010 ROYALTY INVESTMENTS ICAV | Private Equity Fund | $81.1M | $0.1M | 35 |
RTW INNOVATION MASTER FUND, LTD. | Hedge Fund | $3,260.0M | $10.0M | 349 |
RTW MASTER FUND, LTD. | Hedge Fund | $5,060.2M | $10.0M | 1418 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
AURIGEMA, ROBERT, JOHN | Individual | – | PARTNER, CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER | 08/2020 | < 5% |
WONG, RODERICK, TZE IAN | Individual | – | MANAGING PARTNER, CHIEF INVESTMENT OFFICER | 09/2009 | > 75% |
LOUGHRAN, SABERA, REZA | Individual | – | PARTNER EMERITUS | 10/2009 | < 5% |
YALAMANCHI, NAVEEN | Individual | – | PARTNER, PORTFOLIO MANAGER | 01/2016 | 10-25% |
RTW INVESTMENTS GP, LLC | Domestic Entity | – | GENERAL PARTNER OF RTW INVESTMENTS, LP | 04/2016 | < 5% |
PATEL, DARSHAN, VISHNU | Individual | – | CHIEF COMPLIANCE OFFICER | 02/2021 | < 5% |
SIROTA, STEPHANIE, ANNE | Individual | – | PARTNER, CHIEF BUSINESS OFFICER | 01/2014 | < 5% |
FONG, PETER, M | Individual | – | PARTNER, PRESIDENT | 01/2022 | < 5% |
SEITER, CHRISTOPHER, JOHN | Individual | – | CHIEF CORPORATE FINANCE OFFICER | 04/2021 | < 5% |
MAKKER, GOTAM | Individual | – | PARTNER, HEAD OF STRATEGIC INVESTMENTS | 09/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
10X GENOMICS INC | CL A COM | 10M | 503K | – |
89BIO INC | COM | 59M | 7M | – |
ACADIA PHARMACEUTICALS INC | COM | 223M | 14M | – |
ACELYRIN INC | COM | 4M | 978K | – |
ADICET BIO INC | COM | 1M | 1M | – |
AKERO THERAPEUTICS INC | COM | 127M | 5M | – |
ALKERMES PLC | SHS | 170M | 7M | – |
ALLURION TECHNOLOGIES INC | COM SHS | 4M | 4M | – |
APOGEE THERAPEUTICS INC | COM | 107M | 3M | – |
ARCA BIOPHARMA INC | COM | 5M | 1M | – |
ARGENX SE | SPONSORED ADR | 281M | 654K | – |
ARVINAS INC | COM | 79M | 3M | – |
ARYA SCIENCES ACQU CORP IV | CL A | 1M | 128K | – |
AVIDITY BIOSCIENCES INC | COM | 360M | 9M | – |
AXSOME THERAPEUTICS INC | COM | 373M | 5M | – |
BRUKER CORP | COM | 220M | 3M | – |
CARGO THERAPEUTICS INC | COM | 67M | 4M | – |
CG ONCOLOGY INC | COM | 42M | 1M | – |
CULLINAN THERAPEUTICS INC | COM | 18M | 1M | – |
CUTERA INC | COM | 2M | 1M | – |
CYTOKINETICS INC | COM NEW | 147M | 3M | – |
CYTOMX THERAPEUTICS INC | COM | 1M | 1M | – |
DIANTHUS THERAPEUTICS INC | COM | 17M | 667K | – |
DYNE THERAPEUTICS INC | COM | 225M | 6M | – |
ESSA PHARMA INC | COM NEW | 12M | 2M | – |
ESTABLISHMENT LABS HLDGS INC | COM | 122M | 3M | – |
EXAGEN INC | COM | 3M | 2M | – |
FULCRUM THERAPEUTICS INC | COM | 36M | 6M | – |
GH RESEARCH PLC | ORDINARY SHARES | 39M | 3M | – |
GLAUKOS CORP | COM | 46M | 386K | – |
IMMATICS N.V | SHS | 116M | 10M | – |
IMMUNIC INC | COM | 5M | 5M | – |
IMMUNOCORE HLDGS PLC | ADS | 165M | 5M | – |
INSMED INC | COM PAR $.01 | 244M | 4M | – |
INTUITIVE SURGICAL INC | COM NEW | 90M | 202K | – |
KYVERNA THERAPEUTICS INC | COM | 14M | 2M | – |
LENZ THERAPEUTICS INC | COM | 15M | 863K | – |
MADRIGAL PHARMACEUTICALS INC | COM | 537M | 2M | – |
MASIMO CORP | COM | 184M | 1M | – |
MERUS N V | COM | 247M | 4M | – |
MILESTONE PHARMACEUTICALS IN | COM | 4M | 3M | – |
NATERA INC | COM | 281M | 3M | – |
NEUROGENE INC | COM | 39M | 1M | – |
ORCHESTRA BIOMED HLDGS INC | COM | 46M | 6M | – |
PENUMBRA INC | COM | 134M | 742K | – |
PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | 7M | 743K | – |
PROTAGONIST THERAPEUTICS INC | COM | 183M | 5M | – |
PTC THERAPEUTICS INC | COM | 226M | 7M | – |
RADNET INC | COM | 109M | 2M | – |
REGENXBIO INC | COM | 4M | 350K | – |
REPLIMUNE GROUP INC | COM | 10M | 1M | – |
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 21K | 350K | – |
ROCKET PHARMACEUTICALS INC | COM | 381M | 18M | – |
ROIVANT SCIENCES LTD | SHS | 15M | 1M | – |
SAB BIOTHERAPEUTICS INC | COM NEW | 2M | 767K | – |
SAGE THERAPEUTICS INC | COM | 60M | 5M | – |
SAGIMET BIOSCIENCES INC | COM SER A | 2M | 500K | – |
SPYRE THERAPEUTICS INC | COM NEW | 77M | 3M | – |
STOKE THERAPEUTICS INC | COM | 57M | 4M | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 5M | 125K | – |
TARSUS PHARMACEUTICALS INC | COM | 93M | 3M | – |
TAYSHA GENE THERAPIES INC | COM SHS | 42M | 19M | – |
TEMPUS AI INC | CL A | 14M | 400K | – |
TOURMALINE BIO INC | COM | 10M | 742K | – |
ULTRAGENYX PHARMACEUTICAL IN | COM | 134M | 3M | – |
UROGEN PHARMA LTD | COM | 60M | 4M | – |
VERICEL CORP | COM | 37M | 801K | – |
VIRIDIAN THERAPEUTICS INC | COM | 8M | 606K | – |